The Recall Desk
SevereFDA (Drugs)·D-1099-2019·Announced 2019-04-17

FDA Recalls Papaverine-Phentolamine Injectable Due to Insanitary Compounding Conditions

Professional Compounding Pharmacy is recalling Papaverine-Phentolamine 15-0.5mg/mL injectable vials because FDA inspectors observed insanitary conditions during the compounding of sterile drugs.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe severity score under the rubric for significant injury or property damage reports or high-risk contamination scenarios.

Plain-English summary

Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy is recalling specific vials of Papaverine-Phentolamine 15-0.5mg/mL Injectable. The product is a 9ml sterile injectable solution.

The recall was initiated because FDA inspectors observed insanitary conditions during the compounding of sterile drugs during a recent inspection. This lack of processing controls poses a risk to the sterility and safety of the medication.

The affected product was dispensed in Oregon. The specific lot number is 15012019@10, and it was distributed between September 1, 2018, and February 20, 2019. Patients who have received this medication should contact their healthcare provider or the pharmacy for further instructions.

The recalled product

Product
PAPAVERINE-PHENTOLAMINE 15-0.5MGMG/ML INJECTABLE, 9ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot:15012019@10
  • distributed between 09-01-2018 to 02-20-2019.

Distribution

Distributed in 1 state:

Part of a larger recall action

This product is one of 25 recalled by Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 25 products in this recall →